Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kishore M Gadde

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
JAMA|December 19, 2013
Weight loss treatment in obese adultsKishore M Gadde
Expert Opinion on Pharmacotherapy|February 20, 2014
Current pharmacotherapy for obesity: extrapolation of clinical trials data to practiceKishore M Gadde
JAMA|August 10, 2006
Effect of rimonabant on weight and cardiometabolic risk factorsKishore M Gadde
Current Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reductionKishore M Gadde
Postgraduate Medicine|April 2, 2014
Combination phentermine/topiramate for obesity treatment in primary care: a reviewGlen L Xiong, Kishore M Gadde
Evidence-Based Nursing|May 21, 2014
Obesity medications reduce total body weight by 3-9% compared with placebo, when combined with lifestyle changesKishore M Gadde, William S Yancy
Expert Review of Neurotherapeutics|December 26, 2006
Bupropion for weight reductionKishore M Gadde, Glen L Xiong
Lancet (London, England)|November 19, 2021
Long-acting amylin analogue for weight reductionKishore M Gadde, David B Allison
The Lancet. Diabetes & Endocrinology|December 3, 2014
Weight loss: slow and steady does not win the raceCorby K Martin, Kishore M Gadde
Expert Opinion on Pharmacotherapy|April 16, 2020
The limits and challenges of antiobesity pharmacotherapyKishore M Gadde, Katelyn D Atkins
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
JAMA|December 19, 2013
Weight loss treatment in obese adultsKishore M Gadde
Expert Opinion on Pharmacotherapy|February 20, 2014
Current pharmacotherapy for obesity: extrapolation of clinical trials data to practiceKishore M Gadde
JAMA|August 10, 2006
Effect of rimonabant on weight and cardiometabolic risk factorsKishore M Gadde
Current Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
Endocannabinoid receptor antagonists and other emerging pharma-cological strategies for weight reductionKishore M Gadde
Postgraduate Medicine|April 2, 2014
Combination phentermine/topiramate for obesity treatment in primary care: a reviewGlen L Xiong, Kishore M Gadde
Evidence-Based Nursing|May 21, 2014
Obesity medications reduce total body weight by 3-9% compared with placebo, when combined with lifestyle changesKishore M Gadde, William S Yancy
Expert Review of Neurotherapeutics|December 26, 2006
Bupropion for weight reductionKishore M Gadde, Glen L Xiong
Lancet (London, England)|November 19, 2021
Long-acting amylin analogue for weight reductionKishore M Gadde, David B Allison
The Lancet. Diabetes & Endocrinology|December 3, 2014
Weight loss: slow and steady does not win the raceCorby K Martin, Kishore M Gadde
Expert Opinion on Pharmacotherapy|April 16, 2020
The limits and challenges of antiobesity pharmacotherapyKishore M Gadde, Katelyn D Atkins
Pageof 9